Similar causes of various reproductive disorders in early life

Asian Journal of Andrology

Volumn 16, Issue 1, 2014, Pages 50-59

  Svechnikov, Konstantin ^a   Stukenborg, Jan Bernd ^a   Savchuck, Iuliia ^a   Söder, Olle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

endocrine disrupters; male (in)fertility; reproductive disorders; testicular steroidogenesis; testis

Indexed keywords

ANDROGEN; ESTROGEN; GLITAZONE DERIVATIVE; GLUCOCORTICOID; KETOCONAZOLE;

CRYPTORCHISM; ENVIRONMENTAL EXPOSURE; GENITAL SYSTEM DISEASE; HEREDITY; HUMAN; HYPOSPADIAS; LIFESTYLE; MALE GENITAL SYSTEM; NONHUMAN; ORGANOGENESIS; REVIEW; SEX DIFFERENTIATION; SPERM; TESTIS CANCER; VIRILIZATION;

ANDROGENS; ANIMALS; CRYPTORCHIDISM; DISORDERS OF SEX DEVELOPMENT; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; ENVIRONMENTAL POLLUTANTS; FEMALE; GENITALIA, MALE; HUMANS; HYPOSPADIAS; LIFE STYLE; MALE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SEMEN ANALYSIS; SERTOLI CELLS; SEX DIFFERENTIATION; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84891945548     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.4103/1008-682X.122199     Document Type: Review

References (161)

1. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16: 972-8.
2. Sharpe RM. Environmental/lifestyle effects on spermatogenesis. Philos Trans R Soc Lond B Biol Sci 2010;365: 1697-712.
3. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 2012;153: 4097-110.
4. Alexander J, Benford D, Chaudhry Q, Hardy A, Jeger MJ, et al. Scientific Opinion on the hazard assessment of endorcrine disruptors: scientific criteria for indentification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J 2013;11: 84-7.
5. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 2005;113: 1056-61.
6. Buck Louis GM, Gray LE Jr., Marcus M, Ojeda SR, Pescovitz OH, et al. Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008;121 Suppl 3: S192-207.
7. Newbold RR, Padilla-Banks E, Jefferson WN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006;147: S11-7.
8. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009;30: 293-342.
9. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005;308: 1466-9.
10. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol 2010;88: 910-9.
11. Main KM, Skakkebaek NE, Virtanen HE, Toppari J. Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010;24: 279-89.
12. Scott HM, Mason JI, Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev 2009;30: 883-925.
13. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008;118: 1479-90.
14. Svechnikov K, Izzo G, Landreh L, Weisser J, Soder O. Endocrine disruptors and Leydig cell function. J Biomed Biotechnol 2010;2010.
15. Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002;198: 51-9.
16. Wilson JD. Sexual differentiation. Annu Rev Physiol 1978;40: 279-306.
17. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reprod 2003;125: 769-84.
18. Mackay S. Gonadal development in mammals at the cellular and molecular levels. Int Rev Cytol 2000;200: 47-99.
19. Stukenborg JB, Colon E, Soder O. Ontogenesis of testis development and function in humans. Sex Dev 2010;4: 199-212.
20. Sajjad Y, Quenby SM, Nickson P, Lewis-Jones DI, Vince G. Expression of androgen receptors in upper human fetal reproductive tract. Hum Reprod 2004;19: 1659-65.
21. Hughes IA. Minireview: sex differentiation. Endocrinol 2001;142: 3281-7.
22. Baskin LS, Himes K, Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect 2001;109: 1175-83.
23. Kojima Y, Kohri K, Hayashi Y. Genetic pathway of external genitalia formation and molecular etiology of hypospadias. J Pediatr Urol 2010;6: 346-54.
24. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K. German Collaborative Intersex Study Group. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. Eur J Pediatr 1997;156: 7-14.
25. McIntyre BS, Barlow NJ, Foster PM. Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. Toxicol Sci 2001;62: 236-49.
26. Hsieh MH, Breyer BN, Eisenberg ML, Baskin LS. Associations among hypospadias, cryptorchidism, anogenital distance, and endocrine disruption. Current Urol Report 2008;9: 137-42.
27. Hayashi Y, Kojima Y. Current concepts in hypospadias surgery. Int J Urol 2008;15: 651-64.
28. Fredell L, Kockum I, Hansson E, Holmner S, Lundquist L, et al. Heredity of hypospadias and the significance of low birth weight. J Urol 2002;167: 1423-7.
29. Calzolari E, Contiero MR, Roncarati E, Mattiuz PL, Volpato S. Aetiological factors in hypospadias. J Med Genet 1986;23: 333-7.
30. Stoll C, Alembik Y, Roth MP, Dott B. Genetic and environmental factors in hypospadias. J Med Genet 1990;27: 559-63.
31. Fredell L, Iselius L, Collins A, Hansson E, Holmner S, et al. Complex segregation analysis of hypospadias. Hum Genet 2002;111: 231-4.
32. Morgan EA, Nguyen SB, Scott V, Stadler HS. Loss of Bmp7 and Fgf8 signaling in Hoxa13-mutant mice causes hypospadia. Development 2003;130: 3095-109.
33. Yucel S, Liu W, Cordero D, Donjacour A, Cunha G, et al. Anatomical studies of the fibroblast growth factor-10 mutant, Sonic Hedge Hog mutant and androgen receptor mutant mouse genital tubercle. Adv Exp Med Biol 2004;545: 123-48.
34. Beleza-Meireles A, Lundberg F, Lagerstedt K, Zhou X, Omrani D, et al. FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias. Eur J Hum Genet 2007;15: 405-10.
35. Wang Y, Li Q, Xu J, Liu Q, Wang W, et al. Mutation analysis of five candidate genes in Chinese patients with hypospadias. Eur J Hum Genet 2004;12: 706-12.
36. Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, et al. SRD5A2 gene analysis in an Italian population of under-masculinized 46, XY subjects. Clin Endocrinol (Oxf) 2005;63: 375-80.
37. Nordenskjold A, Friedman E, Tapper-Persson M, Soderhall C, Leviav A, et al. Screening for mutations in candidate genes for hypospadias. Urol Res 1999;27: 49-55.
38. Muroya K, Sasagawa I, Suzuki Y, Nakada T, Ishii T, et al. Hypospadias and the androgen receptor gene: mutation screening and CAG repeat length analysis. Mol Hum Reprod 2001;7: 409-13.
39. Ogata T, Muroya K, Ishii T, Suzuki Y, Nakada T, et al. Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene. Clin Endocrinol (Oxf) 2001;54: 835-8.
40. Lim HN, Nixon RM, Chen H, Hughes IA, Hawkins JR. Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 2001;86: 3207-10.
41. Adamovic T, Nordenskjold A. The CAG repeat polymorphism in the androgen receptor gene modifies the risk for hypospadias in Caucasians. BMC Med Genet 2012;13: 109.
42. Ogata T, Wada Y, Fukami M. MAMLD1 (CXorf6): a new gene for hypospadias. Sex Dev 2008;2: 244-50.
43. Miyado M, Nakamura M, Miyado K, Morohashi K, Sano S, et al. Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development. Endocrinol 2012;153: 6033-40.
44. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, et al. CXorf6 is a causative gene for hypospadias. Nat Genet 2006;38: 1369-71.
45. Hayes TB, Collins A, Lee M, Mendoza M, Noriega N, et al. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. Proc Natl Acad Sci USA 2002;99: 5476-80.
46. Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Hum Reprod Update 2001;7: 248-64.
47. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human 'testicular dysgenesis syndrome': a possible model using in utero exposure of the rat to dibutyl phthalate. Hum Reprod 2003;18: 1383-94.
48. Dolk H, Vrijheid M, Armstrong B, Abramsky L, Bianchi F, et al. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet 1998;352: 423-7.
49. Elliott P, Briggs D, Morris S, de Hoogh C, Hurt C, et al. Risk of adverse birth outcomes in populations living near landfill sites. BMJ 2001;323: 363-8.
50. Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, et al. Birth defects in the Seveso area after TCDD contamination. JAMA 1988;259: 1668-72.
51. Garry V F, Harkins ME, Erickson LL, Long-Simpson LK, Holland SE, et al. Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA. Environ Health Perspect 2002;110 Suppl 3: 441-9.
52. Irgens A, Kruger K, Skorve AH, Irgens LM. Birth defects and paternal occupational exposure. Hypotheses tested in a record linkage based dataset. Acta Obstet Gynecol Scand 2000;79: 465-70.
53. Schnitzer PG, Olshan A F, Erickson JD. Paternal occupation and risk of birth defects in offspring. Epidemiol 1995;6: 577-83.
54. Kristensen P, Irgens LM, Andersen A, Bye AS, Sundheim L. Birth defects among offspring of Norwegian farmers, 1967-1991. Epidemiol 1997;8: 537-44.
55. Klip H, Verloop J, van Gool JD, Koster ME, Burger CW, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002;359: 1102-7.
56. Brouwers MM, Feitz W F, Roelofs LA, Kiemeney LA, de Gier RP, et al. Risk factors for hypospadias. Eur J Pediatr 2007;166: 671-8.
57. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 1998;106: 793-6.
58. Vrijheid M, Armstrong B, Dolk H, van Tongeren M, Botting B. Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals. Occup Environ Med 2003;60: 543-50.
59. Bornman R, de Jager C, Worku Z, Farias P, Reif S. DDT and urogenital malformations in newborn boys in a malarial area. BJU Int 2010;106: 405-11.
60. Hussain N, Chaghtai A, Herndon CD, Herson VC, Rosenkrantz TS, et al. Hypospadias and early gestation growth restriction in infants. Pediatr 2002;109: 473-8.
61. Meyer KJ, Reif JS, Veeramachaneni DN, Luben TJ, Mosley BS, et al. Agricultural pesticide use and hypospadias in eastern Arkansas. Environ Health Perspect 2006;114: 1589-95.
62. Akre O, Lipworth L, Cnattingius S, Sparen P, Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiol 1999;10: 364-9.
63. Battin M, Albersheim S, Newman D. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol 1995;12: 425-8.
64. Giordano F, Carbone P, Nori F, Mantovani A, Taruscio D, et al. Maternal diet and the risk of hypospadias and cryptorchidism in the offspring. Paediatr Perinat Epidemiol 2008;22: 249-60.
65. Giordano F, Abballe A, De Felip E, di Domenico A, Ferro F, et al. Maternal exposures to endocrine disrupting chemicals and hypospadias in offspring. Birth Defects Res A Clin Mol Teratol 2010;88: 241-50.
66. Snijder CA, Kortenkamp A, Steegers EA, Jaddoe VW, Hofman A, et al. Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 2012;27: 1191-201.
67. Kollin C, Stukenborg JB, Nurmio M, Sundqvist E, Gustafsson T, et al. Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J Clin Endocrinol Metab 2012;97: 4588-95.
68. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363: 1264-9.
69. Scorer CG. The Descent of the Testis. Arch Dis Child 1964;39: 605-9.
70. Buemann B, Henriksen H, Villumsen AL, Westh A, Zachau-Christiansen B. Incidence of undescended testis in the newborn. Acta Chir Scand Suppl 1961; Suppl 283: 289-93.
71. Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth ME. Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet 1984;2: 330-2.
72. Hutson JM, Hasthorpe S, Heyns C F. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 1997;18: 259-80.
73. Bay K, Virtanen HE, Hartung S, Ivell R, Main KM, et al. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. J Clin Endocrinol Metab 2007;92: 4020-7.
74. Giannopoulos MF, Vlachakis IG, Charissis GC. 13 Years' experience with the combined hormonal therapy of cryptorchidism. Horm Res 2001;55: 33-7.
75. Huhtaniemi I, Alevizaki M. Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 2006;20: 561-76.
76. Nallu A, Mannuel HD, Hussain A. Testicular germ cell tumors: biology and clinical update. Curr Opin Oncol 2013;25: 266-72.
77. Virtanen HE, Bjerknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 2007;96: 611-6.
78. Aschim EL, Nordenskjold A, Giwercman A, Lundin KB, Ruhayel Y, et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 2004;89: 5105-9.
79. Silva-Ramos M, Oliveira JM, Cabeda JM, Reis A, Soares J, et al. The CAG repeat within the androgen receptor gene and its relationship to cryptorchidism. Int Braz J Urol 2006;32: 330-4.
80. Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29: 560-80.
81. Main KM, Kiviranta H, Virtanen HE, Sundqvist E, Tuomisto JT, et al. Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environ Health Perspect 2007;115: 1519-26.
82. Damgaard IN, Skakkebaek NE, Toppari J, Virtanen HE, Shen H, et al. Persistent pesticides in human breast milk and cryptorchidism. Environ Health Perspect 2006;114: 1133-8.
83. Stoker TE, Cooper RL, Lambright CS, Wilson VS, Furr J, et al. In vivo and in vitro anti-androgenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicol Appl Pharmacol 2005;207: 78-88.
84. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 2006;114: 270-6.
85. Stillman RJ. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 1982;142: 905-21.
86. Sharpe RM. The 'oestrogen hypothesis'-where do we stand now? Int J Androl 2003;26: 2-15.
87. Cederroth CR, Schaad O, Descombes P, Chambon P, Vassalli JD, et al. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinol 2007;148: 5507-19.
88. Agoulnik AI. Cryptorchidism-An estrogen spoil? J Clin Endocrinol Metab 2005;90: 4975-7.
89. Jensen MS, Rebordosa C, Thulstrup AM, Toft G, Sorensen HT, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiol 2010;21: 779-85.
90. Kristensen DM, Hass U, Lesne L, Lottrup G, Jacobsen PR, et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2011;26: 235-44.
91. Damgaard IN, Jensen TK, Petersen JH, Skakkebaek NE, Toppari J, et al. Cryptorchidism and maternal alcohol consumption during pregnancy. Environ Health Perspect 2007;115: 272-7.
92. Jensen MS, Bonde JP, Olsen J. Prenatal alcohol exposure and cryptorchidism. Acta Paediatr 2007;96: 1681-5.
93. Mongraw-Chaffin ML, Cohn BA, Cohen RD, Christianson RE. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am J Epidemiol 2008;167: 257-61.
94. Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol 2011;60: 374-9.
95. Pleskacova J, Hersmus R, Oosterhuis JW, Setyawati BA, Faradz SM, et al. Tumor risk in disorders of sex development. Sex Dev 2010;4: 259-69.
96. Kanetsky PA, Mitra N, Vardhanabhuti S, Vaughn DJ, Li M, et al. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum Mol Genet 2011;20: 3109-17.
97. Ferlin A, Pengo M, Pizzol D, Carraro U, Frigo AC, et al. Variants in KITLG predispose to testicular germ cell cancer independently from spermatogenic function. Endocr Relat Cancer 2012;19: 101-8.
98. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril 2008;89: e33-8.
99. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 2006;12: 303-23.
100. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006;27: 468-84.
101. Bretveld R, Brouwers M, Ebisch I, Roeleveld N. Influence of pesticides on male fertility. Scand J Work Environ Health 2007;33: 13-28.
102. Sever LE, Arbuckle TE, Sweeney A. Reproductive and developmental effects of occupational pesticide exposure: the epidemiologic evidence. Occup Med 1997;12: 305-25.
103. Larsen SB, Giwercman A, Spano M, Bonde JP. A longitudinal study of semen quality in pesticide spraying Danish farmers. The ASCLEPIOS Study Group. Reprod Toxicol 1998;12: 581-9.
104. Juhler RK, Larsen SB, Meyer O, Jensen ND, Spano M, et al. Human semen quality in relation to dietary pesticide exposure and organic diet. Arch Environ Contam Toxicol 1999;37: 415-23.
105. Larsen SB, Giwercman A, Spano M, Bonde J P. Seminal characteristics following exposure to pesticides among agricultural workers. Asclepios. Scand J Work Environ Health 1999;25 Suppl 1: 74-5.
106. Padungtod C, Savitz DA, Overstreet JW, Christiani DC, Ryan LM, et al. Occupational pesticide exposure and semen quality among Chinese workers. J Occup Environ Med 2000;42: 982-92.
107. Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod 2001;16: 1768-76.
108. Yucra S, Rubio J, Gasco M, Gonzales C, Steenland K, et al. Semen quality and reproductive sex hormone levels in Peruvian pesticide sprayers. Int J Occup Environ Health 2006;12: 355-61.
109. Huhtaniemi I, Koivisto M, Pakarinen A, Tuimala R, Kauppila A. Pituitary-adrenal and testicular function in preterm infants after prenatal dexamethasone treatment. Acta Paediatr Scand 1982;71: 425-9.
110. Carmichael SL, Ma C, Werler MM, Olney RS, Shaw GM. Maternal corticosteroid use and hypospadias. J Pediatr 2009;155: 39-44.
111. Gitau R, Adams D, Fisk NM, Glover V. Fetal plasma testosterone correlates positively with cortisol. Arch Dis Child Fetal Neonatal Ed 2005;90: F166-9.
112. Sarkar P, Bergman K, Fisk NM, O'Connor TG, Glover V. Amniotic fluid testosterone: relationship with cortisol and gestational age. Clin Endocrinol (Oxf) 2007;67: 743-7.
113. Holson RR, Gough B, Sullivan P, Badger T, Sheehan DM. Prenatal dexamethasone or stress but not ACTH or corticosterone alter sexual behavior in male rats. Neurotoxicol Teratol 1995;17: 393-401.
114. Lalau JD, Aubert ML, Carmignac DF, Gregoire I, Dupouy J P. Reduction in testicular function in rats. II. Reduction by dexamethasone in fetal and neonatal rats. Neuroendocrinol 1990;51: 289-93.
115. Engelhardt D, Weber MM. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 1994;49: 261-7.
116. Berwaerts J, Verhelst J, Mahler C, Abs R. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecol Endocrinol 1999;13: 175-82.
117. Kazy Z, Puho E, Czeizel AE. Population-based case-control study of oral ketoconazole treatment for birth outcomes. Congenit Anom (Kyoto) 2005;45: 5-8.
118. Hallmark N, Walker M, McKinnell C, Mahood IK, Scott H, et al. Effects of monobutyl and di (n-butyl) phthalate in vitro on steroidogenesis and Leydig cell aggregation in fetal testis explants from the rat: comparison with effects in vivo in the fetal rat and neonatal marmoset and in vitro in the human. Environ Health Perspect 2007;115: 390-6.
119. Lambrot R, Muczynski V, Lecureuil C, Angenard G, Coffigny H, et al. Phthalates impair germ cell development in the human fetal testis in vitro without change in testosterone production. Environ Health Perspect 2009;117: 32-7.
120. Taxvig C, Vinggaard AM, Hass U, Axelstad M, Metzdorff S, et al. Endocrine-disrupting properties in vivo of widely used azole fungicides. Int J Androl 2008;31: 170-7.
121. Gray LE Jr., Wolf C, Lambright C, Mann P, Price M, et al. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p, p'-DDE, and ketoconazole) and toxic substances (dibutyl-and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 1999;15: 94-118.
122. Lebovitz HE, Banerji MA. Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 2001;56: 265-94.
123. Arlt W, Auchus RJ, Miller WL. Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta-hydroxysteroid dehydrogenase. J Biol Chem 2001;276: 16767-71.
124. Vierhapper H, Nowotny P, Waldhausl W. Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone. Metabolism 2003;52: 230-2.
125. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81: 3299-306.
126. Yilmaz M, Biri A, Karakoc A, Toruner F, Bingol B, et al. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. J Endocrinol Invest 2005;28: 1003-8.
127. Chan LY, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 2005;83: 955-8.
128. Haddad GF, Jodicke C, Thomas MA, Williams DB, Aubuchon M. Case series of rosiglitazone used during the first trimester of pregnancy. Reprod Toxicol 2008;26: 183-4.
129. Choi JS, Han JY, Ahn HK, Shin JS, Yang JH, et al. Exposure to rosiglitazone and fluoxetine in the first trimester of pregnancy. Diabetes Care 2006;29: 2176.
130. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341: 1392-5.
131. Sharpe RM. Declining sperm counts in men-is there an endocrine cause? J Endocrinol 1993;136: 357-60.
132. Cagen SZ, Waechter JM Jr., Dimond SS, Breslin WJ, Butala JH, et al. Normal reproductive organ development in Wistar rats exposed to bisphenol A in the drinking water. Regul Toxicol Pharmacol 1999;30: 130-9.
133. Ashby J, Tinwell H, Haseman J. Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero. Regul Toxicol Pharmacol 1999;30: 156-66.
134. Takao T, Nanamiya W, Nagano I, Asaba K, Kawabata K, et al. Exposure with the environmental estrogen bisphenol. A disrupts the male reproductive tract in young mice. Life Sci 1999;65: 2351-7.
135. Lee PC. Disruption of male reproductive tract development by administration of the xenoestrogen, nonylphenol, to male newborn rats. Endocrine 1998;9: 105-11.
136. Atanassova N, McKinnell C, Turner KJ, Walker M, Fisher JS, et al. Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels. Endocrinol 2000;141: 3898-907.
137. Ryan BC, Hotchkiss AK, Crofton KM, Gray LE Jr. In utero and lactational exposure to bisphenol A, in contrast to ethinyl estradiol, does not alter sexually dimorphic behavior, puberty, fertility, and anatomy of female LE rats. Toxicol Sci 2010;114: 133-48.
138. Ema M, Fujii S, Furukawa M, Kiguchi M, Ikka T, et al. Rat two-generation reproductive toxicity study of bisphenol A. Reprod Toxicol 2001;15: 505-23.
139. Howdeshell KL, Furr J, Lambright CR, Wilson VS, Ryan BC, et al. Gestational and lactational exposure to ethinyl estradiol, but not bisphenol A, decreases androgen-dependent reproductive organ weights and epididymal sperm abundance in the male long evans hooded rat. Toxicol Sci 2008;102: 371-82.
140. Sharpe RM. Is it time to end concerns over the estrogenic effects of bisphenol A? Toxicol Sci 2010;114: 1-4.
141. Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 2007;115 Suppl 1: 98-105.
142. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008;116: 39-44.
143. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972;112: 1095-100.
144. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996;104 Suppl 4: 741-803.
145. Kellokumpu-Lehtinen P, Pelliniemi LJ, Pulkkinen MO, Schweikert HU. Androgen synthesis in human fetal testis exposed in utero to a combination of norethindrone acetate and ethinyl estradiol. Horm Res 1991;35: 242-5.
146. Whitehead ED, Leiter E. Genital abnormalities and abnormal semen analyses in male patients exposed to diethylstilbestrol in utero. J Urol 1981;125: 47-50.
147. McKinnell C, Atanassova N, Williams K, Fisher JS, Walker M, et al. Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol. J Androl 2001;22: 323-38.
148. Crescioli C, Maggi M, Vannelli GB, Ferruzzi P, Granchi S, et al. Expression of functional estrogen receptors in human fetal male external genitalia. J Clin Endocrinol Metab 2003;88: 1815-24.
149. Cupp AS, Uzumcu M, Suzuki H, Dirks K, Phillips B, et al. Effect of transient embryonic in vivo exposure to the endocrine disruptor methoxychlor on embryonic and postnatal testis development. J Androl 2003;24: 736-45.
150. Johnson L, Staub C, Silge RL, Harris MW, Chapin RE. The pesticide methoxychlor given orally during the perinatal/juvenile period, reduced the spermatogenic potential of males as adults by reducing their Sertoli cell number. Reprod Nutr Dev 2002;42: 573-80.
151. Shi YQ, Wang YP, Song Y, Li HW, Liu CJ, et al. p, p'-DDE induces testicular apoptosis in prepubertal rats via the Fas/FasL pathway. Toxicology Letters 2010;193: 79-85.
152. Elzeinova F, Novakova V, Buckiova D, Kubatova A, Peknicova J. Effect of low dose of vinclozolin on reproductive tract development and sperm parameters in CD1 outbred mice. Reprod Toxicol 2008;26: 231-8.
153. Mathur P P, D'Cruz SC. The effect of environmental contaminants on testicular function. Asian J Androl 2011;13: 585-91.
154. Defamie N, Mograbi B, Roger C, Cronier L, Malassine A, et al. Disruption of gap junctional intercellular communication by lindane is associated with aberrant localization of connexin43 and zonula occludens-1 in 42GPA9 Sertoli cells. Carcinogenesis 2001;22: 1537-42.
155. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, et al. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998; 14: 239-60.
156. Li MW, Mruk DD, Lee WM, Cheng CY. Disruption of the blood-testis barrier integrity by bisphenol A in vitro: is this a suitable model for studying blood-testis barrier dynamics? Int J Biochem Cell Biol 2009;41: 2302-14.
157. Cheng CY, Wong EW, Lie PP, Li MW, Su L, et al. Environmental toxicants and male reproductive function. Spermatogenesis 2011;1: 2-13.
158. Boockfor FR, Blake CA. Chronic administration of 4-tert-octylphenol to adult male rats causes shrinkage of the testes and male accessory sex organs, disrupts spermatogenesis, and increases the incidence of sperm deformities. Biol Reprod 1997;57: 267-77.
159. Aly HA, Domenech O, Abdel-Naim AB. Aroclor 1254 impairs spermatogenesis and induces oxidative stress in rat testicular mitochondria. Food Chem Toxicol 2009;47: 1733-8.
160. Bustos-Obregon E, Gonzalez-Hormazabal P. Effect of a single dose of malathion on spermatogenesis in mice. Asian J Androl 2003;5: 105-7.
161. N'Tumba-Byn T, Moison D, Lacroix M, Lecureuil C, Lesage L, et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal leydig cell function. PLoS One 2012;7: e51579.